nad has been researched along with oxyfedrine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karsanov, NV; Paleev, FN; Paleev, NR; Pronina, VP; Sanina, NP; Sukoian, GV | 1 |
| Galenko-Yaroshevskii, PA; Kanorskii, SG; Zingilevskii, KB | 1 |
| Dzhanashiya, PKh; Salibegashvili, NV; Vladytskaya, OV | 1 |
2 trial(s) available for nad and oxyfedrine
| Article | Year |
|---|---|
Efficiency of refracterin in patients with chronic cardiac insufficiency caused by coronary heart disease.
Topics: Acetyldigoxins; Aged; Cardiac Output, Low; Cardiotonic Agents; Chronic Disease; Coronary Disease; Cytochromes c; Drug Combinations; Echocardiography; Female; Humans; Inosine; Male; Middle Aged; NAD; Oxyfedrine; Systole; Treatment Outcome; Ventricular Function, Left | 2004 |
Efficiency and mechanisms of the antioxidant effect of standard therapy and refracterin in the treatment of chronic heart failure in elderly patients with postinfarction cardiosclerosis.
Topics: Acetyldigoxins; Aged; Aged, 80 and over; Antioxidants; Cardiotonic Agents; Cytochromes c; Drug Combinations; Heart Failure; Humans; Inosine; Myocardial Infarction; NAD; Oxidative Stress; Oxyfedrine; Sclerosis | 2004 |
1 other study(ies) available for nad and oxyfedrine
| Article | Year |
|---|---|
[Chronic cardiac failure in noncoronarogenic myocardial diseases and refracterin effects].
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Biopsy; Cardiomyopathies; Chronic Disease; Cytochrome c Group; Drug Combinations; Female; Heart Failure; Humans; Inosine; Male; Middle Aged; NAD; Oxyfedrine; Treatment Outcome | 1998 |